KIF24 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.711000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.347400E-01
Normal-vs-Stage2
4.873600E-01
Normal-vs-Stage3
6.822200E-02
Normal-vs-Stage4
3.861200E-01
Stage1-vs-Stage2
6.435600E-01
Stage1-vs-Stage3
6.057500E-02
Stage1-vs-Stage4
9.702800E-01
Stage2-vs-Stage3
7.866200E-02
Stage2-vs-Stage4
7.394200E-01
Stage3-vs-Stage4
8.608400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.884200E-01
Normal-vs-AfricanAmerican
6.605800E-01
Normal-vs-Asian
2.168200E-01
Caucasian-vs-AfricanAmerican
5.585200E-01
Caucasian-vs-Asian
6.434200E-01
AfricanAmerican-vs-Asian
2.657200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.200400E-01
Normal-vs-Female
4.119800E-01
Male-vs-Female
9.205000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.901400E-01
Normal-vs-Age(41-60Yrs)
3.690600E-01
Normal-vs-Age(61-80Yrs)
5.178200E-01
Normal-vs-Age(81-100Yrs)
6.036400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.005740E-04
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.634400E-04
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.925000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.258600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.513400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.629200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.695000E-01
Normal-vs-Daily Drinker
4.946800E-01
Normal-vs-Weekly Drinker
3.792600E-01
Normal-vs-Occasional Drinker
5.282200E-01
Normal-vs-Social Drinker
2.385200E-01
Non Drinker-vs-Daily Drinker
4.205200E-01
Non Drinker-vs-Weekly Drinker
2.718400E-01
Non Drinker-vs-Occasional Drinker
3.108400E-01
Non Drinker-vs-Social Drinker
2.972000E-02
Daily Drinker-vs-Weekly Drinker
6.933200E-01
Daily Drinker-vs-Occasional Drinker
7.288200E-01
Daily Drinker-vs-Social Drinker
1.381400E-01
Weekly Drinker-vs-Occasional Drinker
9.966600E-01
Weekly Drinker-vs-Social Drinker
3.216400E-01
Occasional Drinker-vs-Social Drinker
3.595600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.137400E-01
Normal-vs-Grade 2
8.366800E-01
Normal-vs-Grade 3
8.313800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.338600E-01
Grade 1-vs-Grade 3
7.890400E-01
Grade 1-vs-Grade 4
8.137400E-01
Grade 2-vs-Grade 3
9.127800E-01
Grade 2-vs-Grade 4
8.366800E-01
Grade 3-vs-Grade 4
8.313800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.224800E-01
Normal-vs-NonDiabetic
3.990600E-01
Diabetic-vs-NonDiabetic
1.187870E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.266800E-01
Normal-vs-NoPancreatitis
5.345600E-01
Pancreatitis-vs-NoPancreatitis
7.132200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.473600E-01
Normal-vs-N1
4.844200E-01
N0-vs-N1
5.864200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.492000E-01
Normal-vs-TP53-NonMutant
3.344000E-01
TP53-Mutant-vs-TP53-NonMutant
5.732600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
